发明授权
US08796313B2 Substituted dihydroisoindolones as allosteric modulators of glucokinase
有权
取代的二氢异吲哚酮作为葡萄糖激酶的变构调节剂
- 专利标题： Substituted dihydroisoindolones as allosteric modulators of glucokinase
- 专利标题（中）： 取代的二氢异吲哚酮作为葡萄糖激酶的变构调节剂
-
申请号： US11554500申请日： 2006-10-30
-
公开(公告)号： US08796313B2公开(公告)日： 2014-08-05
- 发明人: Joseph Dudash , Philip Rybczynski , Maud Urbanski , Amy Xiang , Roxanne Zeck , Xiaoyan Zhang , Yongzheng Zhang
- 申请人： Joseph Dudash , Philip Rybczynski , Maud Urbanski , Amy Xiang , Roxanne Zeck , Xiaoyan Zhang , Yongzheng Zhang
- 申请人地址： BE Beerse
- 专利权人： Janssen Pharmaceutica N.V.
- 当前专利权人： Janssen Pharmaceutica N.V.
- 当前专利权人地址： BE Beerse
- 代理商 Jeremy K. McKown
- 主分类号： A61K31/4439
- IPC分类号： A61K31/4439 ; C07D401/12
摘要：
The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating glucokinase mediated disorders. More particularly, the compounds of the present invention are glucokinase modulators useful for treating disorders including, but not limited to, type II diabetes.
公开/授权文献
信息查询
IPC分类:
